期刊文献+

Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia 被引量:8

Secretion of melatonin and 6-sulfatoxymelatonin urinary excretion in functional dyspepsia
下载PDF
导出
摘要 To evaluate blood concentration of melatonin and urinary excretion of its metabolite, 6-sulfatoxymelatonin (6-OHMS), in functional dyspepsia (FD). METHODS: Ninety individuals were enrolled in the study: 30 in each study group: patients with postprandial distress syndrome (PDS), epigastric pain syndrome (EPS), and controls. Blood samples were drawn at 02:00 and 09:00 h and 24-h urine collection was performed. Serum melatonin and urinary 6-OHMS concentrations were measured by enzyme-linked immunosorbent assay. RESULTS: Serum melatonin concentration at night and in the morning was significantly (P 〈 0.001) higher inPDS patients [at 02:00 h-93.3 pg/mL, quartile range (QR): 79.8-116.2; at 09.00 h-14.3 pg/mL, QR: 7.06-19.0] than in EPS (57.2 pg/mL, QR: 42.6-73.1, 8.1 pg/mL, QR: 4.2-9.3) and control patients (57.7 pg/mL, QR: 51.2-62.5; 8.1 pg/mL, QR: 5.4-10.3). A similar relationship was observed for urinary 6-OHMS excretion. Patients with severe PDS symptoms had a higher melatonin concentration than these with moderate syndromes, whereas patients with severe EPS had a lower urinary 6-OHMS excretion than patients with moderate symptoms.CONCLUSION: Evaluation of melatonin serum concentrations and 24-h urinary 6-OHMS excretion are useful methods for differential diagnosis of various clinical forms of FD. AIM:To evaluate blood concentration of melatonin and urinary excretion of its metabolite,6-sulfatoxymelatonin(6-OHMS),in functional dyspepsia(FD).METHODS:Ninety individuals were enrolled in the study:30 in each study group:patients with postprandial distress syndrome(PDS),epigastric pain syndrome(EPS),and controls.Blood samples were drawn at 02:00 and 09:00 h and 24-h urine collection was performed.Serum melatonin and urinary 6-OHMS concentrations were measured by enzyme-linked immunosorbent assay.RESULTS:Serum melatonin concentration at night and in the morning was significantly(P < 0.001) higher in PDS patients [at 02:00 h-93.3 pg/mL,quartile range(QR):79.8-116.2;at 09.00 h-14.3 pg/mL,QR:7.06-19.0] than in EPS(57.2 pg/mL,QR:42.6-73.1;8.1 pg/mL,QR:4.1-9.3) and control patients(57.7 pg/mL,QR:51.2-62.5;8.1 pg/mL,QR:5.4-10.3).A similar relationship was observed for urinary 6-OHMS excretion.Patients with severe PDS symptoms had a higher melatonin concentration than these with moderate syndromes,whereas patients with severe EPS had a lower urinary 6-OHMS excretion than patients with moderate symptoms.CONCLUSION:Evaluation of melatonin serum concentrations and 24-h urinary 6-OHMS excretion are useful methods for differential diagnosis of various clinical forms of FD.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第21期2646-2651,共6页 世界胃肠病学杂志(英文版)
基金 Supported by The Ministry of Science and Higher Education of Poland,project NN 402481937
关键词 Functional dyspepsia Postprandial distress syndrome Epigastric pain syndrome MELATONIN 6-sulfatoxymelatonin 血清褪黑激素 消化不良 尿液 排泄 酶联免疫吸附试验 血药浓度 分泌 综合征
  • 相关文献

参考文献41

  • 1Bubenik GA. Localization, physiological significance and possible clinical implication of gastrointestinal melatonin. Biol Signals Recept 2001; 10:350-366.
  • 2Messner M, Huether G, Lorf T, Ramadori G, Schworer H. Presence of melatonin in the human hepatobiliary-gastroin- testinal tract. Life Sci 2001; 69:543-551.
  • 3Reiter RJ, Tan igX, Mayo JC, Sainz RM, Leon J, Czarnocki Z. Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans. Acta Biochim Pol 2003; 50:1129-1146.
  • 4Reiter RJ, Tan DX, Mayo JC, Sainz RM, Leon J, Bandyo- padhyay D. Neurally-mediated and neurally-independent beneficial actions of melatonin in the gastrointestinal tract. ] Physiol Pharmacol 2003; 54 Suppl 4:113-125.
  • 5Hardeland R, Tan DX, Reiter RJ. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an al- most forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
  • 6Cabeza J, Alarcon-de-la-Lastra C, Jimenez D, Martin MJ, Motilva V. Melatonin modulates the effects of gastric injury in rats: role of prostaglandins and nitric oxide. Neurosignals 2003; 12:71-77.
  • 7Sjoblom M, Flemstrom G. Melatonin in the duodenal lu- men is a potent stimulant of mueosal bicarbonate secretion. J Pineal Res 2003; 34:288-293.
  • 8Jaworek J, Brzozowski T, Konturek SJ. Melatonin as an or- ganoprotector in the stomach and the pancreas. J Pineal Res 2005; 38:73-83.
  • 9Kato K, Murai I, Asai S, Takahashi Y, Matsuno Y, Komuro S, Kurosaka H, Iwasaki A, Ishikawa K, Arakawa Y. Central nervous system action of melatonin on gastric acid and pepsin secretion in pylorus-ligated rats. Neuroreport 1998; 9: 3989-3992.
  • 10Kasimay O, Cakir B, Devseren E, Yegen BC. Exogenous melatonin delays gastric emptying rate in rats: role of CCK2 and 5-HT3 receptors. J Physiol Pharmacol 2005; 56:543-553.

同被引文献52

引证文献8

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部